1968
DOI: 10.1136/gut.9.3.270
|View full text |Cite
|
Sign up to set email alerts
|

Effect of corticosteroid therapy on bromsulphthalein excretion in active chronic hepatitis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
2
0
1

Year Published

1970
1970
2016
2016

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(4 citation statements)
references
References 53 publications
1
2
0
1
Order By: Relevance
“…These drugs also have a beneficial influence on hepatic organic anion uptake as evidenced by significantly decreased BSP retention, relative hepatic storage (S) for BSP (Cook, Velasco, and Sherlock, 1968), and, in the present study, an impressive increase in ICG Rmax in the only patient (MM) studied before and after treatment with prednisolone.…”
Section: Discussionsupporting
confidence: 62%
“…These drugs also have a beneficial influence on hepatic organic anion uptake as evidenced by significantly decreased BSP retention, relative hepatic storage (S) for BSP (Cook, Velasco, and Sherlock, 1968), and, in the present study, an impressive increase in ICG Rmax in the only patient (MM) studied before and after treatment with prednisolone.…”
Section: Discussionsupporting
confidence: 62%
“…An increase in Tm has not been described in any disease state. S is usually decreased in patients with hepatocellular disease [11] and is known to increase in the presence of steroids [4], The significance of the changes in Tm and S in our cases is not known.…”
Section: Discussionmentioning
confidence: 82%
“…-Corticoides. Su empleo en las hepatitis crónicas suele producir una rápida mejoría clínica y biológica, disminuyendo la bilirrubina, transaminasas y gammaglobulinas (IgG sobre todo) 20 • 23 • 28 • 34 • 43 • 44 y observándose además un aumento de la albúmina y de la excreción de bromosulftaleina 7 • Reducen la morbilidad y por lo tanto el periodo de hospitalización, así como la mortalidad en los enfermos con HCA, al menos en las series referidas por diversos autores 6 , e, 3o, 36 .…”
Section: Elección Del Fármacounclassified